Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2013

Conditions

HypertensionDiabetes

Interventions

DRUG

nebivolol

Starting at dose of 5 mg daily titrated up to max of 40 mg until target BP of 130/80 is reached

DRUG

Metoprolol

Starting at 50 mg daily dose is titrated to max 200 mg until target BP of 130/80 is reached

Trial Locations (1)

University of Chicago, Chicago